+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cell Culture Market by Product (Consumables, Equipment), Application (Biopharmaceutical Production, Diagnostics, Drug Screening & Development), End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4995205
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell Culture Market grew from USD 26.29 billion in 2023 to USD 30.12 billion in 2024. It is expected to continue growing at a CAGR of 14.58%, reaching USD 68.20 billion by 2030.

This method allows researchers and scientists to study the behavior, biology, and physiology of cells in detail. Cell culture is utilized in various fields, including medical research, pharmaceuticals, biotechnology, and even some aspects of manufacturing. The applications of cell culture technology are vast and varied, encompassing drug development, vaccine production, cancer research, genetic engineering, and the manufacture of biologics, among others. It plays a crucial role in developing new medicines, testing for toxicity, and understanding disease mechanisms. In the pharmaceutical and biotechnology industries, cell culture is pivotal in producing biopharmaceuticals and antibodies. Moreover, its role in regenerative medicine and tissue engineering underlines its significance in developing therapeutic strategies for chronic diseases and conditions. Several factors contribute positively to the growth of the cell culture market, including innovations in cell culture technologies, such as 3D cell culture and automated cell culture systems, growing demand for monoclonal antibodies for therapeutic applications, higher investment in biotechnology and pharmaceutical research activities, and rising incidence of chronic diseases worldwide. However, the cell culture market faces certain limitations, such as the high costs associated with advanced cell culture technologies, ethical issues, the complexity of maintaining cultures, and the risk of contamination. On the other hand, advancements in 3D cell culture technology, the use of cell culture in personalized medicine for tailoring treatments to individual genetic profiles, research into cell culture applications in regenerative medicine, and the burgeoning field of cultured meat, using cell culture for sustainable food production opens new avenues for the development of cell culture market.

Regional Insights

The United States, being a hub for biotechnological research and development, stands out as a significant market for cell culture products. The demand here is driven by a robust research infrastructure, substantial investments in life sciences, and the existence of major pharmaceutical and biotechnology companies. The focus on personalized medicine and regenerative therapies further boosts the market. The South American cell culture market is in a growth phase, fueled by increasing investment in research and development by both public and private sectors. The Asia Pacific region is experiencing rapid growth in cell culture demand due to its expanding biopharmaceutical sector, increasing investments in life sciences, and government support for biotechnology startups. China's market is booming, supported by government initiatives aimed at advancing regenerative medicine, biologics production, and stem cell research. Japan's sophisticated healthcare system and strong emphasis on quality are significant markets for advanced cell culture systems. India's cell culture market is growing, fueled by its burgeoning biotech industry, increased biomedical research, and the production of vaccines and biologics. The EU stands out for its strong research capabilities, regulatory frameworks, and substantial investments in the biotechnology and pharmaceutical sectors. The demand for cell culture products is driven by active research areas, including cancer research, regenerative medicine, and vaccine production. Collaborative research initiatives across member states further enhance the market. The Middle East and Africa region, although emerging, shows potential for growth in cell culture due to increasing healthcare investment and a gradual shift towards research and developmental activities in the life sciences sector.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Cell Culture Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Growing demand for monoclonal antibodies for therapeutic applications
  • Increased investment in biotechnology and pharmaceutical research activities
  • Rising incidence of chronic diseases worldwide

Market Restraints

  • High cost associated with advanced cell culture technologies and the maintenance of sterile conditions

Market Opportunities

  • Expanding the use of cell culture in personalized medicine for tailored treatments to individual genetic profiles
  • Burgeoning demand for cultured meat, using cell culture for sustainable food production

Market Challenges

  • The complexity of maintaining cultures and the risk of contamination

Market Segmentation Analysis

  • Product: Increasing preference for equipments in cell culture for reliability, scalability, and advanced features
  • End-Use: Expanding usage of cell culture in hospitals and diagnostic laboratories for efficiency and diagnostic accuracy

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cell Culture Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cell Culture Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Novartis Embarks on a USD 500 Million Expansion Project in Austrian Biopharmaceutical Manufacturing

Novartis has announced an investment of approximately USD 500 million to enhance its biopharmaceutical production capabilities in Austria. This strategic expansion is set to incorporate two state-of-the-art facilities aimed at boosting the production of cell cultures. By combining technological innovation with a focus on critical healthcare treatments, Novartis's latest venture in Austria aims to enhance biopharmaceutical manufacturing.

Molecular Devices Unveils the CellXpress AI Automated Cell Culture System

Molecular Devices has launched the CellXpress AI automated cell culture system, marking a significant advancement in the field of 3D biology. Aimed at redefining the landscape of drug discovery, this state-of-the-art system combines automation with artificial intelligence to optimize the process of cell culture, a critical step in pharmaceutical research. By facilitating faster and more reliable results, the CellXpress AI system promises to accelerate the journey of potential treatments from the lab to the market.

Strategic Alliance Elevates Stem Cell Research Accessibility and Efficiency

Cell Culture Collective, Inc., a provider of tissue culture reagents and consumables, has announced its new strategic collaboration with Defined Bioscience, marking its appointment as an authorized distributor for Defined Bioscience’s innovative and animal/serum-free stem cell culture solutions. This partnership is set to enhance the research landscape by offering stem cell culture products that promise greater experimental reproducibility, ease of use, and cost-efficiency.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cell Culture Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cell Culture Market, highlighting leading vendors and their innovative profiles. These include Adolf Kühner AG, Advancion Corporation, Agilent Technologies, Inc., Becton, Dickinson, and Company, Bio-Techne Corporation, BioSpherix Ltd., Caisson Labs Inc., CellGenix GmbH, Corning Incorporated, Danaher Corporation, Emulate, Inc., Eppendorf AG, Fujifilm Holdings Corporation, Getinge AB, Hi-Media Laboratories, InSphero AG, Invivogen, Lonza Group, Merck & Co., Inc., Miltenyi Biotec, PAN-Biotech GmbH, PromoCell GmbH, Sartorius AG, Solida Biotech GmBH, STEMCELL Technologies Canada Inc., Synthecon, Incorporated, Thermo Fisher Scientific Inc., and VWR International, LLC by Avantor, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Culture Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product- Consumables

  • Bioreactor Accessories
  • Sera, Media, and Reagents

Media

  • Classical Media & Salts
  • Serum-Free Media
  • Specialty Media
  • Stem Cell Culture Media

Reagents

  • Antibiotics/Antimycotics
  • Attachment & Matrix Factors
  • Balanced Salt Solutions
  • Buffers & Chemicals
  • Cell Dissociation Reagents
  • Contamination Detection Kits
  • Cryoprotective Reagents

Sera

  • Adult Bovine Sera
  • Fetal Bovine Sera

Vessels

  • Cell Factory Systems/Cell Stacks
  • Flasks
  • Multiwell Plates
  • Petri Dishes
  • Roller/Roux Bottles
  • Equipment

Bioreactors

  • Conventional Bioreactors
  • Single-Use Bioreactors

Storage Equipment

  • Cryostorage System
  • Refrigerators & Freezers

Supporting Equipment

  • Autoclaves
  • Biosafety Cabinets
  • Carbon Dioxide Incubators
  • Cell Counters
  • Centrifuges
  • Filtration System
  • Microscopes
  • Application

Biopharmaceutical Production

  • Monoclonal Antibody Production
  • Vaccine Production
  • Diagnostics
  • Drug Screening & Development
  • Stem Cell Research
  • Tissue Engineering & Regenerative Medicine

End-Use

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for monoclonal antibodies for therapeutic applications
5.1.1.2. Increased investment in biotechnology and pharmaceutical research activities
5.1.1.3. Rising incidence of chronic diseases worldwide
5.1.2. Restraints
5.1.2.1. High cost associated with advanced cell culture technologies and the maintenance of sterile conditions
5.1.3. Opportunities
5.1.3.1. Expanding the use of cell culture in personalized medicine for tailored treatments to individual genetic profiles
5.1.3.2. Burgeoning demand for cultured meat, using cell culture for sustainable food production
5.1.4. Challenges
5.1.4.1. The complexity of maintaining cultures and the risk of contamination
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing preference for equipments in cell culture for reliability, scalability, and advanced features
5.2.2. End-Use: Expanding usage of cell culture in hospitals and diagnostic laboratories for efficiency and diagnostic accuracy
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Cell Culture Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Equipment
7. Cell Culture Market, by Application
7.1. Introduction
7.2. Biopharmaceutical Production
7.3. Diagnostics
7.4. Drug Screening & Development
7.5. Stem Cell Research
7.6. Tissue Engineering & Regenerative Medicine
8. Cell Culture Market, by End-Use
8.1. Introduction
8.2. Hospitals & Diagnostic Laboratories
8.3. Pharmaceutical & Biotechnology Companies
8.4. Research & Academic Institutes
9. Americas Cell Culture Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cell Culture Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cell Culture Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Novartis Embarks on a USD 500 Million Expansion Project in Austrian Biopharmaceutical Manufacturing
12.3.2. Molecular Devices Unveils the CellXpress AI Automated Cell Culture System
12.3.3. Strategic Alliance Elevates Stem Cell Research Accessibility and Efficiency
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. CELL CULTURE MARKET RESEARCH PROCESS
FIGURE 2. CELL CULTURE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CELL CULTURE MARKET DYNAMICS
FIGURE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CELL CULTURE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CELL CULTURE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTOR ACCESSORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTOR ACCESSORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CELL CULTURE MARKET SIZE, BY CLASSICAL MEDIA & SALTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CELL CULTURE MARKET SIZE, BY CLASSICAL MEDIA & SALTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CELL CULTURE MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CELL CULTURE MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CELL CULTURE MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CELL CULTURE MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL CULTURE MEDIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL CULTURE MEDIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CELL CULTURE MARKET SIZE, BY ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CELL CULTURE MARKET SIZE, BY ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CELL CULTURE MARKET SIZE, BY ATTACHMENT & MATRIX FACTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CELL CULTURE MARKET SIZE, BY ATTACHMENT & MATRIX FACTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CELL CULTURE MARKET SIZE, BY BALANCED SALT SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CELL CULTURE MARKET SIZE, BY BALANCED SALT SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CELL CULTURE MARKET SIZE, BY BUFFERS & CHEMICALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CELL CULTURE MARKET SIZE, BY BUFFERS & CHEMICALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CELL CULTURE MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CELL CULTURE MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CELL CULTURE MARKET SIZE, BY CONTAMINATION DETECTION KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CELL CULTURE MARKET SIZE, BY CONTAMINATION DETECTION KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOPROTECTIVE REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOPROTECTIVE REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL CELL CULTURE MARKET SIZE, BY ADULT BOVINE SERA, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL CELL CULTURE MARKET SIZE, BY ADULT BOVINE SERA, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL CELL CULTURE MARKET SIZE, BY FETAL BOVINE SERA, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL CELL CULTURE MARKET SIZE, BY FETAL BOVINE SERA, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL CELL CULTURE MARKET SIZE, BY CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL CELL CULTURE MARKET SIZE, BY CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL CELL CULTURE MARKET SIZE, BY FLASKS, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL CELL CULTURE MARKET SIZE, BY FLASKS, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL CELL CULTURE MARKET SIZE, BY MULTIWELL PLATES, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL CELL CULTURE MARKET SIZE, BY MULTIWELL PLATES, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL CELL CULTURE MARKET SIZE, BY PETRI DISHES, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL CELL CULTURE MARKET SIZE, BY PETRI DISHES, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL CELL CULTURE MARKET SIZE, BY ROLLER/ROUX BOTTLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL CELL CULTURE MARKET SIZE, BY ROLLER/ROUX BOTTLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 77. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
TABLE 78. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
TABLE 79. GLOBAL CELL CULTURE MARKET SIZE, BY CONVENTIONAL BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 80. GLOBAL CELL CULTURE MARKET SIZE, BY CONVENTIONAL BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 81. GLOBAL CELL CULTURE MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 82. GLOBAL CELL CULTURE MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 83. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 84. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 85. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 86. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 87. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOSTORAGE SYSTEM, BY REGION, 2018-2023 (USD MILLION)
TABLE 88. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOSTORAGE SYSTEM, BY REGION, 2024-2030 (USD MILLION)
TABLE 89. GLOBAL CELL CULTURE MARKET SIZE, BY REFRIGERATORS & FREEZERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 90. GLOBAL CELL CULTURE MARKET SIZE, BY REFRIGERATORS & FREEZERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 91. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 92. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 93. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 94. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 95. GLOBAL CELL CULTURE MARKET SIZE, BY AUTOCLAVES, BY REGION, 2018-2023 (USD MILLION)
TABLE 96. GLOBAL CELL CULTURE MARKET SIZE, BY AUTOCLAVES, BY REGION, 2024-2030 (USD MILLION)
TABLE 97. GLOBAL CELL CULTURE MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2018-2023 (USD MILLION)
TABLE 98. GLOBAL CELL CULTURE MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2024-2030 (USD MILLION)
TABLE 99. GLOBAL CELL CULTURE MARKET SIZE, BY CARBON DIOXIDE INCUBATORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 100. GLOBAL CELL CULTURE MARKET SIZE, BY CARBON DIOXIDE INCUBATORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 101. GLOBAL CELL CULTURE MARKET SIZE, BY CELL COUNTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 102. GLOBAL CELL CULTURE MARKET SIZE, BY CELL COUNTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 103. GLOBAL CELL CULTURE MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2023 (USD MILLION)
TABLE 104. GLOBAL CELL CULTURE MARKET SIZE, BY CENTRIFUGES, BY REGION, 2024-2030 (USD MILLION)
TABLE 105. GLOBAL CELL CULTURE MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2018-2023 (USD MILLION)
TABLE 106. GLOBAL CELL CULTURE MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2024-2030 (USD MILLION)
TABLE 107. GLOBAL CELL CULTURE MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2023 (USD MILLION)
TABLE 108. GLOBAL CELL CULTURE MARKET SIZE, BY MICROSCOPES, BY REGION, 2024-2030 (USD MILLION)
TABLE 109. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 110. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 111. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 112. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 113. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
TABLE 114. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
TABLE 115. GLOBAL CELL CULTURE MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 116. GLOBAL CELL CULTURE MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 117. GLOBAL CELL CULTURE MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 118. GLOBAL CELL CULTURE MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 119. GLOBAL CELL CULTURE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 120. GLOBAL CELL CULTURE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 121. GLOBAL CELL CULTURE MARKET SIZE, BY DRUG SCREENING & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 122. GLOBAL CELL CULTURE MARKET SIZE, BY DRUG SCREENING & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 123. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 124. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 125. GLOBAL CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 126. GLOBAL CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 127. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 128. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 129. GLOBAL CELL CULTURE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 130. GLOBAL CELL CULTURE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 131. GLOBAL CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 132. GLOBAL CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 133. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 134. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 135. AMERICAS CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 136. AMERICAS CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 137. AMERICAS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 138. AMERICAS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 139. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 140. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 141. AMERICAS CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 142. AMERICAS CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 143. AMERICAS CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 144. AMERICAS CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 145. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
TABLE 146. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
TABLE 147. AMERICAS CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
TABLE 148. AMERICAS CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
TABLE 149. AMERICAS CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 150. AMERICAS CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 151. AMERICAS CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
TABLE 152. AMERICAS CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
TABLE 153. AMERICAS CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 154. AMERICAS CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 155. AMERICAS CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 156. AMERICAS CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 157. AMERICAS CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. AMERICAS CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. AMERICAS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
TABLE 160. AMERICAS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
TABLE 161. AMERICAS CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 162. AMERICAS CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 163. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 164. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 165. ARGENTINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 166. ARGENTINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 167. ARGENTINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 168. ARGENTINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 169. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 170. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 171. ARGENTINA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 172. ARGENTINA CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 173. ARGENTINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 174. ARGENTINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 175. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
TABLE 176. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
TABLE 177. ARGENTINA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
TABLE 178. ARGENTINA CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
TABLE 179. ARGENTINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 180. ARGENTINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 181. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
TABLE 182. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
TABLE 183. ARGENTINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 184. ARGENTINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 185. ARGENTINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 186. ARGENTINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 187. ARGENTINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. ARGENTINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
TABLE 190. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
TABLE 191. ARGENTINA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 192. ARGENTINA CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 193. BRAZIL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. BRAZIL CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. BRAZIL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 196. BRAZIL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 197. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 198. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 199. BRAZIL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 200. BRAZIL CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 201. BRAZIL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 202. BRAZIL CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 203. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
TABLE 204. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
TABLE 205. BRAZIL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
TABLE 206. BRAZIL CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
TABLE 207. BRAZIL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 208. BRAZIL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 209. BRAZIL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
TABLE 210. BRAZIL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
TABLE 211. BRAZIL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 212. BRAZIL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 213. BRAZIL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 214. BRAZIL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 215. BRAZIL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. BRAZIL CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. BRAZIL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
TABLE 218. BRAZIL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
TABLE 219. BRAZIL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 220. BRAZIL CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 221. CANADA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. CANADA CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. CANADA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 224. CANADA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 225. CANADA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 226. CANADA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 227. CANADA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 228. CANADA CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 229. CANADA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 230. CANADA CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 231. CANADA CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
TABLE 232. CANADA CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
TABLE 233. CANADA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
TABLE 234. CANADA CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
TABLE 235. CANADA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 236. CANADA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 237. CANADA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
TABLE 238. CANADA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
TABLE 239. CANADA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 240. CANADA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 241. CANADA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 242. CANADA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 243. CANADA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. CANADA CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. CANADA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
TABLE 246. CANADA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
TABLE 247. CANADA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 248. CANADA CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 249. MEXICO CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 250. MEXICO CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 251. MEXICO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 252. MEXICO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 253. MEXICO CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 254. MEXICO CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 255. MEXICO CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 256. MEXICO CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 257. MEXICO CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 258. MEXICO CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 259. MEXICO CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
TABLE 260. MEXICO CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
TABLE 261. MEXICO CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
TABLE 262. MEXICO CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
TABLE 263. MEXICO CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 264. MEXICO CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 265. MEXICO CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
TABLE 266. MEXICO CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
TABLE 267. MEXICO CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 268. MEXICO CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 269. MEXICO CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 270. MEXICO CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 271. MEXICO CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. MEXICO CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. MEXICO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
TABLE 274. MEXICO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
TABLE 275. MEXICO CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 276. MEXICO CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 277. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 280. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 281. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 282. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 283. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 284. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 285. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 286. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 287. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
TABLE 288. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
TABLE 289. UNITED STATES CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
TABLE 290. UNITED STATES CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
TABLE 291. UNITED STATES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 292. UNITED STATES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 293. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
TABLE 294. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
TABLE 295. UNITED STATES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 296. UNITED STATES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 297. UNITED STATES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 298. UNITED STATES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 299. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 300. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 301. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
TABLE 302. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
TABLE 303. UNITED STATES CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 304. UNITED STATES CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 305. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 306. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 308. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 310. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 311. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 312. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 313. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 314. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 315. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 316. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 317. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
TABLE 318. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
TABLE 319. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
TABLE 320. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
TABLE 321. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 322. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 323. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
TABLE 324. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
TABLE 325. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 326. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 327. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 328. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
TABLE 332. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 334. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 336. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 337. AUSTRALIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 338. AUSTRALIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 339. AUSTRALIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
TABLE 340. AUSTRALIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
TABLE 341. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 342. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 343. AUSTRALIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 344. AUSTRALIA CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 345. AUSTRALIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 346. AUSTRALIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 347. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
TABLE 348. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
TABLE 349. AUSTRALIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
TABLE 350. AUSTRALIA CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
TABLE 351. AUSTRALIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 352. AUSTRALIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 353. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
TABLE 354. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
TABLE 355. AUSTRALIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 356. AUSTRALIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 357. AUSTRALIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 358. AUSTRALIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 359. AUSTRALIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 360. AUSTRALIA C

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Adolf Kühner AG
  • Advancion Corporation
  • Agilent Technologies, Inc.
  • Becton, Dickinson, and Company
  • Bio-Techne Corporation
  • BioSpherix Ltd.
  • Caisson Labs Inc.
  • CellGenix GmbH
  • Corning Incorporated
  • Danaher Corporation
  • Emulate, Inc.
  • Eppendorf AG
  • Fujifilm Holdings Corporation
  • Getinge AB
  • Hi-Media Laboratories
  • InSphero AG
  • Invivogen
  • Lonza Group
  • Merck & Co., Inc.
  • Miltenyi Biotec
  • PAN-Biotech GmbH
  • PromoCell GmbH
  • Sartorius AG
  • Solida Biotech GmBH
  • STEMCELL Technologies Canada Inc.
  • Synthecon, Incorporated
  • Thermo Fisher Scientific Inc.
  • VWR International, LLC by Avantor, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 30.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 68.2 Billion
Compound Annual Growth Rate14.5%
Regions CoveredGlobal

Related Topics

Related Reports

Global Cell Culture Market by Product (Consumables (Media, Sera, Reagents), Vessels (Roller Bottle, Cell Factory, Flask), Equipment (SU Bioreactor, Storage, Incubators, Filtration)), Application (mAbs, Vaccines, Regenerative Medicine) - Forecast to 2029 - Product Image

Global Cell Culture Market by Product (Consumables (Media, Sera, Reagents), Vessels (Roller Bottle, Cell Factory, Flask), Equipment (SU Bioreactor, Storage, Incubators, Filtration)), Application (mAbs, Vaccines, Regenerative Medicine) - Forecast to 2029

  • Report
  • 738 Pages
  • Global
From
Global Life Science Tools Market by Technology (Cell Biology Technology, Genomic Technology, Proteomics Technology), Product (Cell Culture Systems & 3D Cell Culture, Cloning & Genome Engineering, Flow Cytometry), Offerings, Lab Ownership, Lab Size, End-User - Forecast 2024-2030 - Product Image

Global Life Science Tools Market by Technology (Cell Biology Technology, Genomic Technology, Proteomics Technology), Product (Cell Culture Systems & 3D Cell Culture, Cloning & Genome Engineering, Flow Cytometry), Offerings, Lab Ownership, Lab Size, End-User - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Global Cell Culture Consumables And Equipment Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Global Cell Culture Consumables And Equipment Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 155 Pages
  • Global
From
Global Cell Culture Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Global Cell Culture Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 151 Pages
  • Global
From
Cell Culture Consumables And Equipment Global Market Report 2024 - Product Image

Cell Culture Consumables And Equipment Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.